Bioquell PLC (LSE:BQE) - Share price - Overview

Stock Report

Bioquell PLC BQE

Last Price
GBX258.50

Day Change
1.00|0.39%

As of 17/11/2017
14:38:40 GMT | GBX
Minimum 15 Minutes Delay.

Last Close257.50p
Day Range256.55 - 261.65
Mkt Cap58.03Mil
52-Wk Range127.12 - 275.00
Yield %0.00
ISINGB0004992003
Volume5,806
P/E43.47
P/S3.04
P/CF19.50

Share Price

Total Returns 20/11/2017

 Chg (%)  
More ...
Bioquell PLC7.48 
FTSE 100 TR GBP-1.43
 
Financials
201420152016
More ...
Income Statement
Turnover27.2726.8826.49
Operating Profit-4.680.550.05
Net Profit-3.780.640.40
Reported EPS-8.901.501.20
Balance Sheet
Current Assets17.9956.5518.42
Non Current Assets24.1514.3112.23
Total Assets42.1370.8630.65
Current Liabilities7.654.595.93
Total Liabilities11.085.946.82
Total Equity31.0664.9223.83
Cash Flow
Operating Cash Flow3.885.404.24
Net Change in Cash-0.7144.72-39.08
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
20172.448.7947.8929.400.61--
20182.729.7010.3026.652.59--
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
31/05/2017Exercise of OptionMr. Michael Roller73.504,5063,312.00
17/05/2017SaleMr. Michael Roller160.00126,600202,560.00
17/05/2017SaleMr. Michael Roller159.0013,38121,276.00
17/05/2017PurchaseMr. Michael Roller159.2513,38121,309.00

Company Profile

Bioquell PLC is engaged in the design, manufacture, and supply of bio-decontamination and containment equipment. Its products are related to the pharmaceutical, healthcare and defense industries, and testing services to the aerospace, defense.

Sector

Medical Devices

Market Position

1068 of 1833 Companies

Index

FTSE Fledgling

Outlook

(26/07/2017) ch - "...the board believes that the company's profit before taxation for the current financial year will exceed current market expectations"

Next Event 31/12/2017

Next year end (to be reported)
Ratios
CompSecMkt
More ...
PER (E)26.9319.5616.14
Div Yld (E)0.001.654.26
PEG (E)2.031.281.34
ROCE9.9919.7515.81
Op Mrgn5.978.35-9.53
EPS Grwth13.2726.9214.73
Dividends
PreviousLatest
More ...
Record Date06/06/1405/06/15
Ex-Div04/06/1404/06/15
Paid02/07/1402/07/15
Amnt3.303.30

Broker Sentiment

Strong Buy0
Buy0
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanMr. Ian Johnson
Group Finance DirectorMr. Michael Roller
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.